Article
Marker genes for predicting cytokine release syndrome in vitro before CAR T cell infusion
2025-06-10
Abstract excerpt
<title>Abstract</title> <p>Cytokine release syndrome (CRS) and neurotoxicity are common adverse events of the Chimeric antigen receptor (CAR) T cell therapy. Assessing the cytotoxicity associated biomarkers would be essential for therapy design to avoid developing severe toxicities. In this study, we re-analyzed previously published RNAseq results of CAR T cells before infusion and combined it with the clinical r...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0a7ce290-4371-5b51-9f71-6cfc6eb8c579
- DOI
- 10.21203/rs.3.rs-6718121/v1
